DIGITAL & AI MATURITY REPORT 2026 / INDUSTRY FOCUS
Digital & AI Maturity Index in Pharmaceuticals
The pharmaceuticals sector scores 2.84 in the 2026 DAIMI benchmark, trailing the 2.90 baseline. While the industry possesses world-class scientific capability, maturity is held back by “compliance gravity”—structural friction from strict regulation and legacy environments.
To lead in 2026, organizations must overcome these constraints to move AI from experimental pilots into compliant, enterprise-scale production.
Figure 1: Digital & AI Maturity Index (DAIMI) Study Results:
Pharmaceuticals Industry Score, Averages, Leaders, and Laggards
DAIMI Findings: Controlled Excellence vs. The Scaling Challenge
Pharmaceutical performance reveals an industry that is quantitatively strong and well-governed but operationally slow to modernize.
- Core Strengths: Maturity is highest in standardized, tightly controlled environments such as manufacturing and quality management.
- Industrializing AI: While experimentation is high, the sector faces a “maturity trap” where strong controls often default to caution, delaying the operationalization of AI in regulated workflows.
- The Talent Differentiator: Advanced organizations are using upskilling in data literacy to embed analytics directly into daily routines.
A Comprehensive Analysis of Digital & AI Maturity in Pharmaceuticals
To win in 2026, pharma executives must move beyond “AI FOMO” and establish repeatable, compliant pathways for enterprise-wide deployment. Success requires modernizing data foundations and adapting governance to enable speed without compromising quality or trust.
Download the full report to access the detailed DAIMI benchmarks and the strategic roadmap to turn disciplined operations into a sustained digital advantage.
The DAIMI Methodology
DAIMI (Digital and AI Maturity Index) is Digitopia’s framework for assessing how effectively organizations build capability and value in the digital and AI era. It measures maturity across six dimensions—Customer, Operations, Innovation, People, Governance, and Technology—to capture both business outcomes and the foundational capabilities required to deliver them consistently.
Discover how our methodology can transform your strategy.
The Global Perspective
The Pharmaceuticals Focus Report is part of a larger, global study on the state of transformation. Based on six years of research, 1,300+ assessments, and insights from 20+ countries and 10+ industries, the full report offers a truly global perspective.
While AI adoption is accelerating, organizational capability is not. The “Digital & AI Maturity Report 2026” quantifies this gap and provides the strategic blueprint required to close it.
